Bio
Alcoholic and non alcoholic steatohepatitis are major causes of end stage liver disease. My goal as a clinician-scientist is to develop new treatment approaches that improve patient outcomes. My research lab is studying the pathomechanism of liver fibrosis and we are focusing on discovering novel therapies and translating them to clinical care.
Clinical Focus
- Gastroenterology
- Hepatology
- Liver transplant
Academic Appointments
-
Professor - Med Center Line, Medicine - Gastroenterology & Hepatology
-
Member, Bio-X
Honors & Awards
-
Fellow, American Association for Studies of Liver Diseases (2016)
-
elected member, American Society for Clinical Investigation (2014)
-
Boris Ruebner and John Rosenquist Excellence in Teaching Award, UC Davis (2014)
Boards, Advisory Committees, Professional Organizations
-
Editorial Board, Hepatology (2017 - Present)
-
Associate Editor, Hepatology Communications (2017 - Present)
-
Associate Editor, Seminars in Liver Disease (2017 - Present)
-
Associate Editor, American Journal of Physiology Gastrointestinal and Liver Physiology (2015 - 2018)
-
Member, AASLD, Research Awards Committee (2016 - Present)
-
Member, American Liver Foundation Research Awards Committee (2016 - Present)
-
Regular member, NIH HBPP Study Section (2012 - 2016)
-
Data Monitoring Committee, NASH Clinical Research Network, NIH (2012 - Present)
Professional Education
-
Board Certification: American Board of Internal Medicine, Gastroenterology (2003)
-
Residency: Mayo Clinic Internal Medicine Residency (1999) MN
-
Board Certification, American Board of Internal Medicine, Gastroenterology (2004)
-
Fellowship: Mayo Clinic Gastroenterology Fellowship (2003) MN
-
Board Certification: American Board of Internal Medicine, Internal Medicine (2000)
-
Medical Education: Semmelweis Univ Med School (1988) Hungary